Home › Capsugel Expands Global Manufacturing For Finished Dosage Forms
 

Keywords :   


Capsugel Expands Global Manufacturing For Finished Dosage Forms

2013-09-20 03:30:50| drugdiscoveryonline News Articles

Capsugel’s Dosage Form Solutions (DFS) business unit unveiled extensive upgrades and expansions to three of its manufacturing facilities in the United States and Europe, deepening the company’s finished dosage form capabilities as part of its LIPIDEX technology platform.

Tags: global forms manufacturing finished

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.06PPG to Announce Second-quarter 2024 Results July 18
26.06Fresh Coat for First Responders: New Hampshire Fire Station Gets a Makeover by California Paints
26.06Michigan Sets Record Recycling Rate in 2023, Recycles Nearly 70,000 Tons of Materials
26.06Companies Seek Federal EPR: How Producers Can Prepare
26.06Q&A with GFLs Tyler Stefure: Integrating New Fleet Tech & Upholding GFL Values
26.06SWANA Publishes Report on the Performance of Seattles Zero Waste System
26.06Baltimore Sues Major Brands for Alleged Role in Plastic Pollution Crisis
26.06Petco Aims Sight at Large-Scale Recycling Program to Divert LDPE Plastic from Landfills
More »